Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Letting Update

13 Jun 2013 09:00

RNS Number : 9677G
Derwent London PLC
13 June 2013
 



13 June 2013

 

Derwent London pre-lets two major developments at Turnmill EC1 and 40 Chancery Lane WC2 to Publicis Groupe for a combined annual rent of £8.8 million

 

Derwent London plc ("Derwent London"/"the Group") announces that it has pre-let all the office accommodation, totalling 155,600 sq ft (14,460m2), at Turnmill, 63 Clerkenwell Road EC1 and 40 Chancery Lane WC2, two of its current schemes. The space has been let to agencies within Publicis Groupe, one of the world's leading communications groups.

 

At Turnmill, the office rent will be £3.1 million per annum on 58,200 sq ft (5,410m2) leaving 12,300 sq ft (1,140m2) of retail space to be let with a December 2012 estimated rental value (ERV) of £0.4 million. At 40 Chancery Lane, the office rent will be £5.7 million per annum on 97,400 sq ft (9,050m2), which leaves 4,400 sq ft (410m2) of retail space to be let with a December 2012 ERV of £0.1 million. Derwent London's share of the office rent, after deducting a ground rent, will be £7.8 million per annum.

 

Both leases are for a term of 20 years with rent reviews every five years and a rent-free period equivalent to 32 months. There is a tenant's break in year 18 which, if exercised, will result in a penalty becoming payable.

 

Derwent London is currently on site at both developments and they are expected to be handed to Publicis Groupe for fit out in July 2014.

 

Turnmill is a 70,500 sq ft (6,550m2) new office and retail development on a prominent corner site, which the Group holds freehold, opposite Farringdon station, where a Crossrail interchange is under construction. The office space is arranged over the five upper floors, with a ground floor reception.

 

40 Chancery Lane will be a 101,800 sq ft (9,460m2) seven-storey building located on a large Midtown corner site. The Group holds a 128-year headlease with a ground rent equal to 18% of the rent received. It has the right to reduce this gearing to 10% through the payment of a premium to the freeholder.

 

Whilst Turnmill and 40 Chancery Lane are being completed, agencies of Publicis Groupe will continue to occupy their existing offices at Derwent London's 80 Charlotte Street W1. Therefore, the start of the Group's 385,000 sq ft (35,800m2) redevelopment of this property is now likely to commence in the first half of 2015 with completion scheduled for the second half of 2017.

 

Derwent London is on site at projects totalling over 400,000 sq ft (37,200m2), including Turnmill and 40 Chancery Lane. Over the next 12 months the Group will start construction of a further 345,500 sq ft (32,050m2) with our White Collar Factory offices at Old Street EC1, retail space at 18-30 Tottenham Court Road W1 complementing our current office scheme at 1-2 Stephen Street W1 (together 127,000 sq ft/ 11,800m2) and a residential development at 73 Charlotte Street W1.

 

John Burns, Chief Executive Officer at Derwent London, commented:

 

"We are delighted that Publicis Groupe has chosen to remain a tenant of the Group and to occupy two of our new developments. Their decision endorses the quality of our product, the rising attractions of London's vibrant Tech Belt and the broadening of the tenant base in Midtown. These transactions will mean that we have pre-let 74% of the projects where we are on site. Our next major project will start early next year at White Collar Factory, in the heart of the Tech Belt, which leaves a further 1.9 million sq ft of potential development for delivery before 2020."

 

-ends-

 

For further information please contact:

 

Derwent London 020 7659 3000

 

John Burns, Chief Executive Officer

 

Paul Williams, Executive Director

 

Celine Thompson, Head of Leasing

 

 

Brunswick Group 020 7404 5959

 

Elizabeth Adams

 

Sheena Shah

 

 

Notes to editors

 

Derwent London

 

Derwent London owns a portfolio of commercial real estate predominantly in central London valued at £2.9bn as at 31 December 2012, making us the largest London-focused real estate investment trust (REIT).

 

Our experienced team has a proven record of value creation through development, refurbishment and asset management activities. We take a fresh approach to each building, adopting a design-led and tenant-led philosophy. We focus on buildings with reversionary mid-market rents, particularly those in improving locations around the West End and the City borders.

 

The business is grounded on a strong balance sheet with modest leverage, a robust income stream and flexible financing.

 

Landmark schemes in our portfolio of 5.4 million sq ft (505,800m2) as at 31 December 2012 include Angel Building EC1, Buckley Building EC1, Qube W1, Horseferry House SW1 and Tea Building E1.

 

Derwent London came seventh overall in the 2012 Management Today awards for 'Britain's Most Admired Companies', topping the real estate sector for the third year in a row. Earlier in 2012 the Group won the Estates Gazette Property Company of the Year - Offices award. Last year the Tea Building also won a RIBA regional award and an AJ Retrofit award for the 'Green Tea' refurbishment to improve the environmental performance of the building.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKNDPOBKKQAD
Date   Source Headline
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company
29th Aug 20254:45 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.